Involvement of cytochrome P450 and the flavin-containing monooxygenase(s) in the sulphoxidation of simple sulphides in human liver microsomes

被引:4
|
作者
Nnane, IP
Damani, LA
机构
[1] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA
[2] Chinese Univ Hong Kong, Dept Pharm, Shatin, Peoples R China
关键词
sulphide; sulphoxide; sulphoxidation; chromatography;
D O I
10.1016/S0024-3205(03)00290-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study was conducted to examine the involvement of cytochrome P450 (CYP450) and the flavin-containing monooxygenase (FMO) in the sulphoxidation of ethyl methyl sulphide (EMS), 4-chlorophenyl methyl sulphide (CPMS) and diphenyl sulphide (DPS) in human liver microsomes from a phenotypic CYP2D6 extensive metabolizer. Human liver microsomes catalyzed the sulphoxidation of EMS, CPMS and DPS to their corresponding sulphoxides. Lineweaver-Burk plots for the sulphoxidation of EMS in human liver microsomes indicated that the apparent K-m and V-max were 1.53 +/- 0.07 mM and 1.11 +/- 0.25 nmoles/mg protein/min, respectively. The apparent K-m and V-max for the sulphoxidation of CPMS were 0.17 +/- 0.05 mM and 1.41 +/- 0.16 nmoles/mg protein/min, respectively. The apparent K-m and V-max for the sulphoxidation of DPS were 0.10 +/- 0.01 mM and 1.08 +/- 0.05 nmoles/mg protein/min, respectively. Methimazole noncompetitively inhibited the sulphoxidation of EMS, CPMS and DPS by human liver microsomes with K-i values of 8.6 +/- 0.6, 5.7 +/- 0.4 and 6.6 +/- 0.5 mM, respectively. SKF525A noncompetitively inhibited the sulphoxidation of CPMS and DPS by human liver microsomes with K-i values of 6.6 +/- 0.4 and 0.40 +/- 0.1 mM, respectively. The results suggest that FMO is involved in the sulphoxidation of EMS, CPMS and DPS while CYP450 is involved in the sulphoxidation of CPMS and DPS in human liver microsomes. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:359 / 369
页数:11
相关论文
共 50 条
  • [41] FLAVIN-CONTAINING MONOOXYGENASE MEDIATED METABOLISM OF PSYCHOACTIVE-DRUGS BY HUMAN BRAIN MICROSOMES
    BHAMRE, S
    BHAGWAT, SV
    SHANKAR, SK
    BOYD, MR
    RAVINDRANATH, V
    BRAIN RESEARCH, 1995, 672 (1-2) : 276 - 280
  • [42] Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver
    Koyama, N
    Sasabe, H
    Miyamoto, G
    XENOBIOTICA, 2002, 32 (07) : 573 - 586
  • [43] Identification of Human Cytochrome P450 and Flavin-Containing Monooxygenase Enzymes Involved in the Metabolism of Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine 2C Agonist
    Usmani, Khawja A.
    Chen, Weichao G.
    Sadeque, Abu J. M.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 761 - 771
  • [44] Synergistic action of flavin containing NADH dependant azoreductase and cytochrome P450 monooxygenase in azoaromatic mineralization
    Oturkar, Chetan C.
    Othman, Munif A.
    Kulkarni, Mahesh
    Madamwar, Datta
    Gawai, Kachru R.
    RSC ADVANCES, 2013, 3 (09): : 3062 - 3070
  • [45] Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems
    Indra, Radek
    Pompach, Petr
    Vavrova, Katarina
    Jaklova, Katefina
    Heger, Zbynek
    Adam, Vojtech
    Eckschlager, Tomag
    Kopeacova, Katefina
    Arlt, Volker Manfred
    Stiborova, Marie
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2020, 74
  • [46] RAT HEPATIC-MICROSOMAL METABOLISM OF ETHYLENETHIOUREA - CONTRIBUTIONS OF THE FLAVIN-CONTAINING MONOOXYGENASE AND CYTOCHROME-P-450 ISOZYMES
    DECKER, CJ
    DOERGE, DR
    CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) : 482 - 489
  • [47] THE ROLE OF CYTOCHROMES-P-450 AND FLAVIN-CONTAINING MONOOXYGENASE IN THE METABOLISM OF (S)-NICOTINE BY RABBIT LUNG
    WILLIAMS, DE
    SHIGENAGA, MK
    CASTAGNOLI, N
    DRUG METABOLISM AND DISPOSITION, 1990, 18 (04) : 418 - 428
  • [48] Effect of total parenteral nutrition and choline on hepatic flavin-containing and cytochrome P-450 monooxygenase activity in rats
    Cashman, JR
    Lattard, V
    Lin, J
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) : 222 - 229
  • [49] METABOLIC OXIDATION OF CARCINOGENIC ARYLAMINES BY RAT, DOG, AND HUMAN HEPATIC MICROSOMES AND BY PURIFIED FLAVIN-CONTAINING AND CYTOCHROME-P-450 MONOOXYGENASES
    HAMMONS, GJ
    GUENGERICH, FP
    WEIS, CC
    BELAND, FA
    KADLUBAR, FF
    CANCER RESEARCH, 1985, 45 (08) : 3578 - 3585
  • [50] In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO):: metabolism of benzydamine and caffeine by FMO and P450 isoforms
    Lang, DH
    Rettie, AE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (04) : 311 - 314